| First Shared by | Shares | URL | Content | Date |
|---|---|---|---|---|
| @ASCOPost | 13 | http://www.ascopost.com/News/58736 | .@US_FDA Approves Nivolumab/Ipilimumab Combination in Intermediate- or Poor-Risk Advanced RCC http://www.ascopost.com/News/58736 #kcsm #oncology |
16-Apr-18 18:50
|
| @ASCOPost | 10 | http://www.ascopost.com/News/58756 | .@ASCO Clinical Practice Guideline Update: Fertility Preservation in Patients With Cancer http://www.ascopost.com/News/58756 #oncology |
21-Apr-18 13:46
|
| @ASCOPost | 8 | http://www.ascopost.com/News/58744 | KEYNOTE-189: Addition of Pembrolizumab to Chemotherapy in Metastatic NSCLC http://www.ascopost.com/News/58744 #LCSM #oncology #AACR18 |
17-Apr-18 20:25
|
| @weldeiry | 8 | http://www.ascopost.com/videos/the-policy-politics-law-of-cancer/levi-garraway-drug-development-cost/ | RT @ASCOPost: Levi Garraway, MD, PhD, on Drug Development and the Cost of Researching and Treating Cancer http://www.ascopost.com/videos/the-policy-politics-law-of-cancer/levi-garraway-drug-development-cost/ #oncology… |
21-Apr-18 16:07
|
| @cancer_tm | 7 | http://www.freebookspot.es/Comments.aspx | #Therapies Team-Based Oncology Care The Pivotal Role of Oncology Navigation. [http://www.freebookspot.es/Comments.aspx?Element_ID=1295774] #Oncology https://t.co/caVM5z3ZEx |
17-Apr-18 12:22
|
| @ONCOassist | 6 | https://www.nytimes.com/2018/04/16/health/lung-cancer-immunotherapy.html | Lung cancer patients live longer with immunotherapy via @NYTHealth https://goo.gl/fucPTK #oncology #innovation |
16-Apr-18 18:31
|
| @ASCOPost | 6 | http://www.ascopost.com/News/58727 | Wait for Diagnostic Testing and Effect on Outcomes in Patients With Cancer http://www.ascopost.com/News/58727 #oncology |
17-Apr-18 15:15
|
| @ASCOPost | 6 | http://www.ascopost.com/News/58739 | Dual Inhibition of IDO1 and PD-L1 Safe in Patients With Advanced Solid Tumors http://www.ascopost.com/News/58739 #oncology #AACR18 |
18-Apr-18 14:00
|
| @ASCOPost | 6 | http://www.ascopost.com/News/58747 | New Liquid Biopsy–Based Cancer Model Reveals Data on Chemoresistance in SCLC http://www.ascopost.com/News/58747 #lcsm #oncology #AACR18 |
18-Apr-18 19:50
|
| @ASCOPost | 6 | http://www.ascopost.com/News/58752 | Pembrolizumab Monotherapy in NSCLC Meets Primary Endpoint in Phase III KEYNOTE-042 Study http://www.ascopost.com/News/58752 #LCSM #oncology |
20-Apr-18 15:57
|
-
- .@US_FDA Approves Nivolumab/Ipilimumab Combination in Intermediate- or Poor-Risk Advanced RCC http://www.ascopost.com/News/58736 #kcsm #oncology
-
- .@ASCO Clinical Practice Guideline Update: Fertility Preservation in Patients With Cancer http://www.ascopost.com/News/58756 #oncology
-
- KEYNOTE-189: Addition of Pembrolizumab to Chemotherapy in Metastatic NSCLC http://www.ascopost.com/News/58744 #LCSM #oncology #AACR18
-
- RT @ASCOPost: Levi Garraway, MD, PhD, on Drug Development and the Cost of Researching and Treating Cancer http://www.ascopost.com/videos/the-policy-politics-law-of-cancer/levi-garraway-drug-development-cost/ #oncology…
-
- #Therapies Team-Based Oncology Care The Pivotal Role of Oncology Navigation. [http://www.freebookspot.es/Comments.aspx?Element_ID=1295774] #Oncology https://t.co/caVM5z3ZEx
-
- Lung cancer patients live longer with immunotherapy via @NYTHealth https://goo.gl/fucPTK #oncology #innovation
-
- Wait for Diagnostic Testing and Effect on Outcomes in Patients With Cancer http://www.ascopost.com/News/58727 #oncology
-
- Dual Inhibition of IDO1 and PD-L1 Safe in Patients With Advanced Solid Tumors http://www.ascopost.com/News/58739 #oncology #AACR18
-
- New Liquid Biopsy–Based Cancer Model Reveals Data on Chemoresistance in SCLC http://www.ascopost.com/News/58747 #lcsm #oncology #AACR18
-
- Pembrolizumab Monotherapy in NSCLC Meets Primary Endpoint in Phase III KEYNOTE-042 Study http://www.ascopost.com/News/58752 #LCSM #oncology